Literature DB >> 293671

An endothelial cell growth factor from bovine hypothalamus: identification and partial characterization.

T Maciag, J Cerundolo, S Ilsley, P R Kelley, R Forand.   

Abstract

Extracts of bovine hypothalamus were found to contain a significant level of mitogenic activity when tested in a Swiss 3T3 cell [3H]dThd incorporation assay and in a human umbilical vein endothelial cell growth assay. The mitogenic activity responsible for 3T3 cell activity was purified and characterized as a fibroblast growth factor (FGF)-like mitogen. Neither the biologically active FGF-like mitogen purified from the hypothalamus extracts nor FGF purified from bovine pituitary glands was mitogenic when added to human endothelial cells in vitro, suggesting the presence of more than one mitogen in the hypothalamic extracts. The 3T3 and endothelial cell biological activities of hypothalamic extracts were both found to be inactivated by trypsin, subtilisin, and heat treatment, but were stable to dialysis. The endothelial cell growth factor activity could be efficiently separated from the FGF activity by gel exclusion chromatography. The endothelial cell mitogen possessed a molecular weight of approximately 75,000, whereas that of FGF was approximately 15,000. The endothelial cell growth factor activity was found to be inactivated with reducing agents whereas the 3T3 cell mitogenic activity was stable after incubation with 2-mercaptoethanol. Significant levels of endothelial cell mitogenic activity were also found in extracts of bovine brain and pituitary glands.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 293671      PMCID: PMC411712          DOI: 10.1073/pnas.76.11.5674

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  10 in total

1.  Purification of a fibroblast growth factor from bovine pituitary.

Authors:  D Gospodarowicz
Journal:  J Biol Chem       Date:  1975-04-10       Impact factor: 5.157

Review 2.  Factors involved in the modulation of cell proliferation in vivo and in vitro: the role of fibroblast and epidermal growth factors in the proliferative response of mammalian cells.

Authors:  D Gospodarowicz; G Greenburg; H Bialecki; B R Zetter
Journal:  In Vitro       Date:  1978-01

3.  The subendothelium and thrombogenesis.

Authors:  M B Stemerman; T H Spaet
Journal:  Bull N Y Acad Med       Date:  1972-02

4.  Increased permeability of capillaries to protein during thrombocytopenia. An experimental study in the rabbit.

Authors:  I Aursnes
Journal:  Microvasc Res       Date:  1974-05       Impact factor: 3.514

5.  Tumor angiogenesis: iris neovascularization at a distance from experimental intraocular tumors.

Authors:  M A Gimbrone; S B Leapman; R S Cotran; J Folkman
Journal:  J Natl Cancer Inst       Date:  1973-01       Impact factor: 13.506

6.  Purification of the fibroblast growth factor activity from bovine brain.

Authors:  D Gospodarowicz; H Bialecki; G Greenburg
Journal:  J Biol Chem       Date:  1978-05-25       Impact factor: 5.157

7.  The nerve growth factor: purification as a 30,000-molecular-weight protein.

Authors:  V Bocchini; P U Angeletti
Journal:  Proc Natl Acad Sci U S A       Date:  1969-10       Impact factor: 11.205

8.  Nerve growth factor in mouse saliva. Rapid isolation procedures for and characterization of 7 S nerve growth factor.

Authors:  L E Burton; W H Wilson; E M Shooter
Journal:  J Biol Chem       Date:  1978-11-10       Impact factor: 5.157

9.  Control of proliferation of human vascular endothelial cells. Characterization of the response of human umbilical vein endothelial cells to fibroblast growth factor, epidermal growth factor, and thrombin.

Authors:  D Gospodarowicz; K D Brown; C R Birdwell; B R Zetter
Journal:  J Cell Biol       Date:  1978-06       Impact factor: 10.539

10.  Human vascular endothelial cells in culture. Growth and DNA synthesis.

Authors:  M A Gimbrone; R S Cotran; J Folkman
Journal:  J Cell Biol       Date:  1974-03       Impact factor: 10.539

  10 in total
  163 in total

1.  RGD-dependent vacuolation and lumen formation observed during endothelial cell morphogenesis in three-dimensional fibrin matrices involves the alpha(v)beta(3) and alpha(5)beta(1) integrins.

Authors:  K J Bayless; R Salazar; G E Davis
Journal:  Am J Pathol       Date:  2000-05       Impact factor: 4.307

Review 2.  Regulation of tissue injury responses by the exposure of matricryptic sites within extracellular matrix molecules.

Authors:  G E Davis; K J Bayless; M J Davis; G A Meininger
Journal:  Am J Pathol       Date:  2000-05       Impact factor: 4.307

3.  Heparin/endothelial cell growth supplement regulates matrix gene expression and prolongs life span of vascular smooth muscle cells through modulation of interleukin-1.

Authors:  J Y Hsu; M Y Hsu; T Sorger; M Herlyn; E M Levine
Journal:  In Vitro Cell Dev Biol Anim       Date:  1999 Nov-Dec       Impact factor: 2.416

4.  Capillary morphogenesis during human endothelial cell invasion of three-dimensional collagen matrices.

Authors:  G E Davis; S M Black; K J Bayless
Journal:  In Vitro Cell Dev Biol Anim       Date:  2000-09       Impact factor: 2.416

5.  The TspanC8 subgroup of tetraspanins interacts with A disintegrin and metalloprotease 10 (ADAM10) and regulates its maturation and cell surface expression.

Authors:  Elizabeth J Haining; Jing Yang; Rebecca L Bailey; Kabir Khan; Richard Collier; Schickwann Tsai; Steve P Watson; Jon Frampton; Paloma Garcia; Michael G Tomlinson
Journal:  J Biol Chem       Date:  2012-10-03       Impact factor: 5.157

6.  Effect of temperature on in vitro proliferative activity of human umbilical vein endothelial cells.

Authors:  Q R Yang; D V Berghe
Journal:  Experientia       Date:  1995-02-15

7.  Antilipopolysaccharide factor from horseshoe crab, Tachypleus tridentatus, inhibits lipopolysaccharide activation of cultured human endothelial cells.

Authors:  C E Desch; P O'Hara; J M Harlan
Journal:  Infect Immun       Date:  1989-05       Impact factor: 3.441

8.  Rickettsial interactions with human endothelial cells in vitro: adherence and entry.

Authors:  T S Walker
Journal:  Infect Immun       Date:  1984-05       Impact factor: 3.441

9.  Increased adhesion of human monocytes to IL-4-stimulated human venous endothelial cells via CD11/CD18, and very late antigen-4 (VLA-4)/vascular cell adhesion molecule-1 (VCAM-1)-dependent mechanisms.

Authors:  E M Verdegaal; H Beekhuizen; I Blokland; R van Furth
Journal:  Clin Exp Immunol       Date:  1993-08       Impact factor: 4.330

10.  Cloning of two novel forms of human acidic fibroblast growth factor (aFGF) mRNA.

Authors:  R A Payson; H Canatan; M A Chotani; W P Wang; S E Harris; R L Myers; I M Chiu
Journal:  Nucleic Acids Res       Date:  1993-02-11       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.